COMPANY PROFILES

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent addition to the RaySearch product line is RayIntelligence®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. 

Mevion Medical Systems is the leading provider of compact proton therapy systems for cancer care.

Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy.

Since 2013, Mevion compact proton therapy single-room systems have been used by leading cancer centers for treating patients.

Mevion’s series of products, including the flagship MEVION S250i and MEVION S250-FIT with HYPERSCAN pencil beam scanning, represent the world’s most compact proton therapy systems that eliminate the obstacles of size, complexity, and cost.

Mevion is headquartered in Littleton, Massachusetts with a presence in Europe and Asia.

For more information, please visit www.mevion.com.

IBA is your worldwide innovation leader in the field of proton therapy with future technologies such as DynamicARC® and ConformalFLASH® on our Proteus® platform.

Thanks to our innovative mindset, we have remained ahead of the curve and built the largest community of proton therapy users who have treated more than 140,000 patients globally.

Together we form the most knowledgeable proton therapy community in the world. We are not mere providers, we are real partners.

Company profile coming soon ...

Founded in 2007, P-Cure is at the forefront of democratizing Proton Therapy, offering the most compact FDA-cleared solution for treating cancer patients. P-Cure's comprehensive system enables the planning and treatment of patients with Proton Therapy in both supine and seated positions, fitting linac-like vaults within existing/new radiation therapy centers.

• Operating globally with production, service, and R&D platforms in the US, Israel, and China, P-Cure collaborates closely with healthcare providers supporting them in achieving unprecedented return on investment with operating breakeven typically within a year of implementation.
• P-Cure is dedicated to ushering in a new era of life-saving technology accessible to all oncology centers and their patients, revolutionizing the cancer treatment landscape worldwide

Varian has long been on a mission to help create a world without fear of cancer.

Now, as a Siemens Healthineers company, we are working as one, based on a more expansive perspective of the patient's journey than ever before.

As a result, our vision for the future – and what we can achieve on behalf of patients – has expanded and become much more comprehensive.

Given the broad portfolio of imaging and cancer care technologies and services that we offer as one unified company, we are working together to create an oncology ecosystem that enables us to support care providers along the entire cancer care continuum.

CQ Medical is the global leader in patient radiotherapy positioning and healthcare innovations that advance human care.

From researchers and scientists to designers and developers, CQ Medical is at the forefront of cutting-edge, patient-centric medical technology designed to deliver the best possible outcomes.

Orfit brings high precision and comfort to the positioning and immobilization of cancer patients in proton therapy thanks to devices that perfectly pair with advanced proton therapy delivery techniques.

Aerial®, an award-winning proton couch top, optimizes the impact on proton dose.

Combined with Nanor® masks we provide greater patient comfort while ensuring stability and reproducibility.

Hitachi is the leading particle therapy system provider worldwide.

With decades of experience in radiation therapy, Hitachi delivers reliable proton, carbon-ion, and hybrid systems.

By incorporating an upright patient positioning system, Hitachi also offers compact treatment solutions that combine robustness and innovation.

From design and construction to long-term operation and maintenance, Hitachi enables partners to choose the best treatment options that fit their needs. 

Veracyte is a global diagnostics company advancing precision medicine through genomic testing.

Its genitourinary oncology portfolio, including Decipher® Prostate, Decipher® Bladder, and the TrueMRD™ Monitoring Test for MIBC, delivers clinically validated genomic insights that help inform decision-making, improve understanding of tumor biology, and support more personalized care across the prostate and bladder cancer care continuums.

RAD provides design-built modular facilities for the healthcare industry including radiotherapy vaults and clinics, proton vaults and clinics, and other specialty healthcare facilities.

Our customized, factory fabricated solutions are completed up to 50% faster than standard construction and are installed for temporary, interim or permanent use.

RAD’s long-standing vendor-neutral approach allows all modular medical facilities to be designed around the medical equipment manufacturer and technology that best meets each customer’s needs.

RAD’s Operating Leases require no capital, allowing projects to commence and complete sooner and customers to generate revenue faster.

Launched in 2014 as the official journal of the Particle Therapy Co-Operative Group, it is the mission of IJPT to provide a preferred venue for disseminating the most up-to-date information on the clinical, physical, and biological research in proton, light-ion, and heavy charged-particle therapy.

Since its founding, IJPT has published articles by nearly 300 prominent radiation oncologists, physicists, and dosimetrists from 200 institutions around the world.